Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice-Reference-Cited by-同舟云学术

Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice

Published:2013-01 Issue:1 Volume:2 Page:1-7
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Hekele Armin¹,Bertholet Sylvie²,Archer Jacob¹,Gibson Daniel G³,Palladino Giuseppe¹,Brito Luis A¹,Otten Gillis R¹,Brazzoli Michela²,Buccato Scilla²,Bonci Alessandra²,Casini Daniele²,Maione Domenico²,Qi Zhi-Qing³,Gill John E³,Caiazza Nicky C³,Urano Jun³,Hubby Bolyn³,Gao George F⁴,Shu Yuelong⁴,De Gregorio Ennio²,Mandl Christian W¹,Mason Peter W¹,Settembre Ethan C¹,Ulmer Jeffrey B¹,Craig Venter J³,Dormitzer Philip R¹,Rappuoli Rino²,Geall Andrew J²

Affiliation:

1. Novartis Vaccines and Diagnostics, Cambridge, MA 02139, USA

2. Novartis Vaccines and Diagnostics, Siena 53100, Italy

3. Synthetic Genomics, Inc., La Jolla, CA 92037, USA

4. Chinese Center for Disease Control and Prevention, Beijing 102206, China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

http://www.nature.com/articles/emi201354.pdf

Reference31 articles.